|
⚲
|
| Keyboard |
| Fust Matthew K
✚
|
|
|---|---|
| CIK # | 0001397266 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001397266] | |
| 4 | [0001397266] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-06-11 | Grant | 6,900 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 10,350 | $0.00 | |
|
Atara Biotherapeutics Inc ATRA
Common Stock
|
2025-06-10 | Grant | 7,828 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 85,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 85,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 80,000 | $0.00 | |
|
Ultragenyx Pharmaceutical Inc RARE
Common Stock
|
2025-05-15 | Grant | 5,740 | $0.00 | |
|
Ultragenyx Pharmaceutical Inc RARE
Stock Option (Right to Buy) · derivative
|
2025-05-15 | Grant | 10,787 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 85,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 85,586 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 27,802 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-10-18 | Option exercise | 6,205 | $8.79 | 54,542 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-10-18 | Option exercise | 7,844 | $2.52 | 19,767 |
| showing 20 of 200 most recent transactions | |||||